1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Chemotherapy Prior to RAPA-201 Therapy: new trials by email Literature Review of Chemotherapy Prior to RAPA-201 Therapy trials Research Report on Chemotherapy Prior to RAPA-201 Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy - Malignant Melanoma With Metastasis, Malignant Melanoma | Phase 2 | Not yet recruiting | Rapa Therapeutics LLC | 65 | 2027-03-01 | 2026-03-19 |
| RAPA-201 Therapy of Solid Tumors RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy, Pembrolizumab (PD-1 Blocking Antibody) - Solid Tumor, Small Cell and Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Rapa Therapeutics LLC | 37 | 2021-08-01 | 2025-05-14 |
Melanoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
United States (2)